日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Q and A with CEO

J&J is helping to build a healthy China

By Li Xiang | China Daily | Updated: 2018-05-08 09:39
Share
Share - WeChat
The booth of Johnson & Johnson Medical at an international medical equipment exhibition in Beijing. [Photo provided to China Daily]

Editor's Note: This year marks the 40th anniversary of China's reform and opening-up. China Daily interviewed top executives of well-known multinational companies for their views on the country's socioeconomic development.

CEO & chairman: Company to sustain investment in innovation, which is set to play a key role in transforming nation's healthcare industry

Please use three words to describe China's changes in the past 40 years.

Dynamic, innovative and inspiring

What are the biggest achievements in China since the introduction of the reform and opening-up policy 40 years ago?

The rapid development of the healthcare industry over the last 40 years in China has been remarkable, as has the resultant improvement in the health and well-being of the Chinese people.

China has substantially increased investment to expand health infrastructure and strengthen its primary-care system. This has greatly reduced child and maternal mortality rates, and improved the general health and life expectancy of the Chinese people.

Johnson & Johnson was one of the earliest multinational pharmaceutical companies to enter China after economic reforms started in the late 1970s, and over the years, we have been committed to meeting the healthcare needs of people in China and to supporting the government's efforts to build a patient-centered and pro-innovation healthcare system. We look forward to continuing to support the Healthy China 2030 agenda.

What's the biggest challenge China faces today and how can the country overcome it?

Within healthcare, there continue to be unmet health and wellness needs. A vibrant healthcare innovation ecosystem is essential to addressing the unmet healthcare needs, which Johnson & Johnson will continue to support.

We believe the transformative potential of new technologies in healthcare being developed in China, including artificial intelligence, big data and cloud computing, will play a key role in promoting more flexible healthcare, in order to meet the needs of patients and consumers.

How has your company benefited from the reform and opening-up policy?

We're optimistic about China's progress in building a healthy China and believe various macro trends indicate that there are significant opportunities for innovation to play a key role in transforming the nation's healthcare industry.

We've been in the Chinese mainland since 1985, and we've been privileged to support the government's efforts to reach and serve more patients, doctors, and to help families and communities thrive.

We currently employ about 10,000 people across more than 90 sites in China. We also make significant investments in research and development as well as manufacturing. For example, we are building a state-of-the-art manufacturing facility in Xi'an.

Sustaining investment in innovation is an important aspect of Johnson & Johnson's strategy. We have made important strategic investments to better serve consumers and patients in the country, including the acquisitions of Elsker Mother & Baby and Dabao Cosmetics.

More recently, we entered into a worldwide collaboration with Genscript Biotech Corporation's subsidiary, Legend Biotech, to develop a new CAR T-cell drug candidate for multiple myeloma.

We plan to continue that approach, and in 2019 will open JLABs@Shanghai, which is an incubator site for startup companies that we expect will contribute to the expansion of the life sciences industry in China.

Has competition intensified between Johnson & Johnson and Chinese companies?

Everyone in the healthcare system wins with better competition. That usually results in better products and services, leading to better outcomes. So, we welcome that and realize that in order to remain at the forefront, we must continue to invest and employ the very best talent in the country.

How do you view China's role in the world today?

The government's commitment to expanding healthcare has been remarkable. The government's support and leadership in fostering greater digital connectivity, and tech and life science entrepreneurialism, put China in a good position to lead the world into a healthier future.

What measures are needed if China wants to deepen reforms?

I've been encouraged by the efforts to build an innovation-driven economy and a patient-centered healthcare system in China. Healthy China 2030 is an action plan that will advance innovation as part of the larger comprehensive overhaul of the healthcare system, and the government work report outlines a number of reforms, including raising medical insurance benefits and strengthening efforts to increase the number of general practitioners. Those steps, among others, will be essential to the process and ultimate success of the program.

What is the most unforgettable experience you have had in China?

I have visited China many times and every time I come here, I am impressed with the new development and new opportunities it presents. In March, I attended the China Development Forum in Beijing, and it was a great honor to be there on behalf of the 130,000 employees of Johnson& Johnson around the world who are dedicated to serving and helping patients and consumers live longer, happier and healthier lives.

Apart from economic development, what progress in other fields have you witnessed in China in the past 40 years?

Technological innovation in China is very exciting right now. We are committed to continuing to support that, as well as the efforts happening across the country to build a patient-centered and pro-innovation healthcare system.

Alex Gorsky, CEO and chairman of Johnson & Johnson. [Photo provided to China Daily]

CV

Name: Alex Gorsky

Age: 57

Nationality: United States

Career:
2012-present: CEO and chairman of Johnson & Johnson

2011: Vice-chairman of Johnson & Johnson's executive committee

2009: Worldwide chairman of the medical devices and diagnostics segment of Johnson & Johnson

2008: Group chairman of Ethicon Inc of Johnson & Johnson

2004: Head of pharmaceuticals business of Novartis Pharmaceuticals Corp North America

2003: Group chairman of Johnson & Johnson's pharmaceuticals business in Europe, the Middle East and Africa

2001: President of Janssen Pharmaceutica

1988: Sales representative at Janssen Pharmaceutica

Education:
Bachelor of Science degree from the US Military Academy at West Point, New York MBA from The Wharton School of the University of Pennsylvania

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 操网 | 男女进进出出动态图啪啪 | 色偷偷网 | 国产在线精品一区 | 午夜视频在线观看免费观看在线观看 | 久久国产日韩 | 国产成人免费高清激情明星 | 成人免费一区二区三区视频软件 | 日本一区二区在线视频 | 国产在线精品一区二区三区 | 免费中文字幕日韩欧美 | 午夜久久视频 | 久久亚洲这里只有精品18 | 久久久国产精品免费A片蜜臀 | 日本视频不卡 | 成人午夜大片免费视频77777 | 波多久久夜色精品国产 | 亚洲精品人人 | 激情国产视频 | 欧美伦理一区 | 91免费版在线观看 | 麻豆污视频 | 午夜剧场在线免费观看 | 秋霞理论在线视频 | 精品AV一区二区三区久久 | 午夜精品在线 | 狠狠色噜噜狠狠狠狠米奇7777 | av在线电影网站 | 国产精品18hdxxxⅹ在线 | 日本精品一区二区三区在线 | 亚洲国产精品一区二区第一页 | 中文字字幕在线 | 天天操天天爱天天干 | 欧美在线观看视频网站 | 狠狠做深爱婷婷久久一区 | 丝袜美腿中文字幕 | 色综合久久88色综合天天 | 天天影视综合网 | 国产中文视频 | 中文在线国产 | av色在线观看 |